FBXO22 is a potential therapeutic target for recurrent chondrosarcoma
Baoquan Xin(University of Shanghai for Science and Technology), Tielong Liu(Shanghai Changzheng Hospital), Zhi Zhu(Shanghai Changzheng Hospital), Qiujing Guan(East China Normal University), Guangjian Bai(University of Shanghai for Science and Technology), Hui Chen(Shanghai Jiao Tong University), Cheng Yang(Shanghai Changzheng Hospital), Xīn Gào(Qingdao University), WeiWei Zou(Shanghai Changzheng Hospital), Lei Li(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 3
Related Papers
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Essential requirement for two-pore channel 1 in NAADP-mediated calcium signaling
|The Journal of Cell Biology|2009|406
Regulatory Role of G Protein–Coupled Estrogen Receptor for Vascular Function and Obesity
|Circulation Research|2009|366
Prostate Cancer, Version 3.2024
|Journal of the National Comprehensive Cancer Network|2024|289
The Burden of Gastrointestinal Anastomotic Leaks: an Evaluation of Clinical and Economic Outcomes
|Journal of Gastrointestinal Surgery|2014|271